Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...

Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...

Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

The firm should move into full commercialization of its Z1 triple taper hip stem in the second half of 2025, leveraging the Z1's versatility and ease of installation. Zimmer Biomet also recently ...

Through the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment to outpace hips and knees, moving forward, according to a Feb. 6 report from Medtech ...

(Reuters) - Medical device maker Zimmer Biomet Holdings forecast full-year ... due to strong demand for its devices used in hip and knee procedures. Combined sales at Zimmer's hips and knees ...